Age-Related Macular Degeneration (AMD) Market

1
Global Age-Related Macular Degeneration (AMD)
Market Expected to Grow at 7.6 CAGR During 2016
2022
2
Global Age-Related Macular Degeneration (AMD)
The global age-related macular degeneration
market was valued at 5,335.7 million in 2015,
and it is expected to grow at a CAGR of 7.6
during 2016 - 2022. Among the various types, the
wet AMD segment is expected to witness the faster
growth compared to dry AMD segment, during the
forecast period. The global age-related macular
degeneration market is growing at a significant
rate, due to increasing healthcare cost, and
increasing prevalence lifestyle associated
diseases, such as obesity and hypertension. In
addition, the growing geriatric population,
increasing prevalence of AMD and increasing
pipeline drugs for AMD are also driving the
growth of the global age-related macular
degeneration market. Explore Report with Detailed
TOC at https//www.psmarketresearch.com/market-an
alysis/age-related-macular-degeneration-market
3
Global Age-Related Macular Degeneration (AMD)
The information and data in the publication
Global Age-related Macular Degeneration Market
Size, Share, Development, Growth and Demand
Forecast to 2022 represent the research and
analysis of data from various primary and
secondary sources. The bottom-top approach has
been used to calculate the global market size by
type. PS Market Research analysts and
consultants interacted with authorities from
leading companies of the concerned domain, to
substantiate every value of data presented in the
report. The company bases its primary research on
discussions with prominent professionals and
analysts in the industry, which is followed by
informed and detailed, online, and offline
research. Age-related macular degeneration (AMD)
is an acquired retinal disorder indicated by
fundus changes. It is one of the most common
forms of visual impairment in the geriatric
population. It is a deterioration or degeneration
of macular, leading to vision loss among people
aged 60 years and above. The macula is a small
part of retina responsible for sharpness and
central vision.
4
Global Age-Related Macular Degeneration (AMD)
Smoking, obesity, high blood pressure, high
cholesterol, poor diet, ultra-violet radiation,
hereditary, and light eye color are some of the
risk factors associated with AMD. In early
stages, macular degeneration may not have
symptoms, although with the progress of the
disease it may have symptoms such as
deterioration in central vision or dark spot, and
blurriness. Factors such as stringent regulatory
requirements and increase in off label use are
inhibiting the growth of the global market. The
increasing awareness of AMD is the key trend
observed in the global age-related macular
degeneration market. Geographically, North
America dominated the global market of
age-related macular degeneration in 2015
whereas, the Asia-Pacific market is expected to
witness the fastest growth, during the forecast
period. Some of the key companies operating in
the global age-related macular degeneration
market include Novartis AG, F. Hoffmann-La Roche
Ltd., Bayer AG, Regeneron Pharmaceutical, Inc.,
Acucela, Ophthotech Corporation, Neurotech
Pharmaceuticals, Inc., GlaxoSmithKline plc,
StemCells Inc and Alimera Sciences, Inc.
5
Global Age-Related Macular Degeneration (AMD)
Download report sample at
https//www.psmarketresearch.com/market-analysis/a
ge-related-macular-degeneration-market/report-samp
le
6
GET IN TOUCH
THANK YOU!
For information regarding permissions and other
queries Kindly write to
US/Canada Toll-Free 1-888-778-7886